Statistical considerations in the use and analysis of single-subject designs.
暂无分享,去创建一个
[1] A. Kirby,et al. Sample size estimation using repeated measurements on biomarkers as outcomes. , 1994, Controlled clinical trials.
[2] K. Ottenbacher,et al. The statistical analysis of single-subject data: a comparative examination. , 1994, Physical therapy.
[3] J. Rochon. A statistical model for the "N-of-1" study. , 1990, Journal of clinical epidemiology.
[4] S. Spechler,et al. Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). , 1994, Controlled clinical trials.
[5] H. Petersen,et al. Statistical aspects of controlled single subject trials. , 1990, Family practice.
[6] D. Reboussin,et al. Neuropeptide Y is a neuromodulator of pulsatile luteinizing hormone-releasing hormone release in the gonadectomized rhesus monkey. , 1992, Endocrinology.
[7] Moricizine and quality of life in the Cardiac Arrhythmia Suppression Trial II (CAST II). , 1994, Controlled clinical trials.
[8] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[9] S C Hayes,et al. Single case experimental design and empirical clinical practice. , 1981, Journal of consulting and clinical psychology.
[10] B T Bates,et al. The effect of trial size on statistical power. , 1992, Medicine and science in sports and exercise.
[11] A. Kazdin,et al. Methodological and interpretive problems of single-case experimental designs. , 1978, Journal of consulting and clinical psychology.
[12] J. Phillips. Serially correlated errors in some single-subject designs , 1983 .
[13] G H Guyatt,et al. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. , 1990, Annals of internal medicine.